GERMANTOWN, Md., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announces it has achieved its latest milestone in the second phase of its collaboration with the Hospital Infantil Universitario Niño Jesús (“Hospital”) in Madrid, Spain.
Read more at globenewswire.comOrgenesis reaches next milestone in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here